Leonardo Biosystems

company

About

Leonardo Biosystems is a provider of a proprietary multistage drug delivery platform for the treatment of cancer.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$1.25M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
1 - 10
Operating Status
Active

Leonardo Biosystems, Inc., a Houston, TX-based provider of a proprietary multistage drug delivery platform initially targeting the treatment of cancer.

Founded in 2005 and based on a technology of Dr. Mauro Ferrari, President of the Methodist Hospital Research Institute in Houston, Leonardo has a multi-stage delivery platform that consists of fully biodegradable, porous silicon particles (smaller than a red blood cell), which can be loaded with a diverse array of secondary nanoparticles such as liposomes, micelles, carbon nanotubes, dendrimers and metallic nanoparticles. These particles can be designed to seek out tumor vasculature and can be tuned to create an intravascular depot, providing sustained release following a single intravenous injection.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.25M
Leonardo Biosystems has raised a total of $1.25M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2011 Series Unknown $1.25M 1 Texas Wide Open for Business Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Leonardo Biosystems is funded by 1 investors. Texas Wide Open for Business are the most recent investors.
Investor Name Lead Investor Funding Round
Texas Wide Open for Business Yes Series Unknown